

(Sharecast News) - Contract research organisation Hvivo said on Monday that it has signed a £2.0m contract with a new biopharmaceutical client to...


(Sharecast News) - hVIVO reported positive results from a phase 2a respiratory syncytial virus (RSV) human challenge trial conducted on behalf of Shio...


(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory sy...


(Sharecast News) - hVIVO announced on Monday that it has signed a contract with Inhalon Biopharma to conduct a human challenge trial assessing the eff...


(Alliance News) - hVIVO PLC on Wednesday released an optimistic pre-annual results trading update, and said it expects "further strong growth" next ye...


(Sharecast News) - Contract research organisation Hvivo said on Wednesday that it has acquired two clinical research units from German outfit CRS Clin...


(Sharecast News) - hVIVO announced on Monday that it has signed a letter of intent with ILiAD Biotechnologies to conduct a pivotal phase three human c...


(Alliance News) - hVIVO PLC on Monday said it had signed a letter of intent to run phase 3 trials on ILiAD Biotechnologies LLC's whooping cough vaccin...